Novartis, Elan Sue IPC Over Generic Focalin XR
By Ben James · March 30, 2011, 5:59 PM EDT
Novartis Pharma AG and Elan Corp. PLC slapped Intellipharmaceutics Corp. with patent infringement suits in New Jersey and Delaware on Friday over the company's efforts to market a generic version of...
To view the full article, register now.